The sequential development of the expression of the Lewis and secretor gene systems in red cells and saliva was studied in normal infants by both qualitative and semiquantitative serological methods. Infants who are Lewis-positive (Le/ ) secretors (Se/ ) are red cell type Le(a –– b –– x + ) at birth; within a week they become Le(a + b –– x + ), then Le(a + b + x + ) and at approximately 2 years attain the adult phenotype Le(a –– b + x + ). In Lewis-positive (Le/ ) nonsecretors (se/se),maturation stops at the Le(a + b –– x + ) phase. Lewis-negative (leile) infants remain Le(a –– b –– x –– ). The salivary expression of the Lewis and secretor genes, however, are fully developed at birth. Compared to term infants, premature infants exhibit a more delayed maturation of these gene systems. These studies show the rate of maturation and tissue expressivity of the Lewis and secretor genes in the red cells and secretory tissues during the perinatal period is not synchronous; red cell expression lags behind that in saliva. The data also suggest that the Le gene governs the production of two antigens, Lea and Lex, and that Lex is the only antenatal red cell expression of the Le gene wich gives rise phenotypically to the unique Lewis type of the newborn Le(a –– b –– x + ).Lea, although repressed during intrauterine life, is activated rapidly within a few days after birth. The secretor gene activates later; its first red cell expression, the Leb antigen, may be evident between the first week and the fourth month of postnatal life. Its full expression, the complete conversion to Le(a –– b + x +) may take up to 2 years; it is during this transition phase that the second unique infantile type Le(a + b + x + ) is found. In the case of the Lewis-negative (leile) infant, the salivary studies suggest that the fetal le gene is not an amorph but is activated late in intrauterine life and undergoes a gradual but partial inactivation during the perinatal period. That the fetal se gene is also weakly active during the perinatal period and is then totally inactivated within the first year of life is suggested by the findings from two nonsecretor (se/se) infants.

Keywords:
ABH, Cord red cells, Lewis antigens, Perinatal, Saliva, Secretor
This content is only available via PDF.
© 1973 S. Karger AG, Basel
1973
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.